Home » Topics » Regulatory » EMA

EMA
RSS

EMA committee recommends approval of Rezolsta, announces darunavir label extensions

Sep. 30, 2014

Boehringer Ingelheim's nintedanib receives positive opinion for second-line therapy of NSCLC

Sep. 29, 2014

Signifor recommended by CHMP to treat patients with acromegaly

Sep. 29, 2014

EMA committee recommends European approval of Cyramza

Sep. 29, 2014

Harvoni recommended for the treatment of chronic hepatitis C

Sep. 29, 2014

EMA committee hands down positive opinion on Trulicity

Sep. 29, 2014

EMA committee recommends approval of Moventig

Sep. 29, 2014

EMA recommends ketoconazole for approval in Cushing's syndrome

Sep. 29, 2014

CHMP recommends approval of aclidinium bromide/formoterol fumarate

Sep. 29, 2014

Oxabact awarded E.U. orphan drug designation for short bowel syndrome

Sep. 25, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...